Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid

Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):172-4.

Abstract

To study the efficacy of the combination of albendazole and prednisolone for the treatment of eosinophilic meningitis, we conducted a pilot study among Thai patients with eosinophilic meningitis. Patients were given a 2-week course of prednisolone, 60 mg/day and albendazole, 15 mg/kg/ day. The primary observation parameter was the number of patients who still had headache after the 2-week course of treatment. Twenty-six patients were enrolled in the study. There were 3 (11.5%) patients who still had headache after the 2-week course of treatment and the median length of time until complete disappearance of headache was 4 days. Serious side effects were not detected. Treatment for 2 weeks with the combination regimen of albendazole and prednisolone is safe and effective for the treatment of eosinophilic meningitis.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Albendazole / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Eosinophilia / diagnosis
  • Eosinophilia / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Meningitis, Aseptic / diagnosis
  • Meningitis, Aseptic / drug therapy*
  • Middle Aged
  • Prednisolone / administration & dosage*
  • Prospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Thailand
  • Treatment Outcome

Substances

  • Prednisolone
  • Albendazole